El interés en corto de Edesa Biotech da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Edesa Biotech. Los datos de interés en corto se actualizan cada dos semanas.

Edesa Biotech (NASDAQ:EDSA) Bolsa, Informe de interés en corto

Edesa Biotech

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

AMOD

DGLY

EDSA

El Índice de Precios al Productor en EE. UU. subió un 3,5% en enero, superando las previsiones. ¿Cómo reaccionaron los mercados?

Acciones de EE. UU. reaccionan al alza tras el aumento del PPI: ¿qué esperar ahora?

Edesa Biotech Inc

A wave of full-shopping boycotts has taken hold in parts of Europe, with consumers in the Balkans leading the charge against skyrocketing grocery prices. Now, a movement in the U.S. is adopting a similar strategy—but for an entirely different reason.
<h2 class="wp-block-heading">European Consumers Push Back Against Rising Costs</h2>
Shoppers across the Balkans recently organized supermarket boycotts to protest soaring food prices and a worsening cost of living crisis. Under the leadership of the consumer rights organization Hello, Inspector, the campaign began in Croatia and swiftly expanded to Bosnia and Herzegovina, Montenegro, and Serbia.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Supermarket aisles were quiet across Croatia on Friday as consumers protested high food prices by joining a boycott on shopping.<a href="https://t.co/GdEHFdOW1R">https://t.co/GdEHFdOW1R</a> <a href="https://t.co/4lNLN132LS">pic.twitter.com/4lNLN132LS</a>
&mdash; AFP News Agency (@AFP) <a href="https://twitter.com/AFP/status/1882851895741743418?ref_src=twsrc%5Etfw">January 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>
The boycott had an immediate impact. In Croatia alone, supermarket transactions dropped by 44%, and total sales plunged by 53%, according to tax authorities. In response, the Croatian government increased the number of price-capped essentials from 30 to 70. In an attempt to regain customers, grocery chains such as Kaufland and Konzum announced price reductions and frozen prices on a few products.
Even Montenegro's prime minister expressed support for the movement, stating that &#8220;as a citizen, I support such action.&#8221;
Trending: They call it the &#8216;Biggest Disruption To IP Since Disney&#8217; and their funding window is closing . <a href="https://www.benzinga.com/money/elf-labs-1">Less than 24 hours left&nbsp; for investors to claim shares at just $2/share with $980 minimum.</a>
<h2 class="wp-block-heading">A Different Kind of Boycott Emerges in the U.S.</h2>
While Europeans are protesting high prices, Latinos in the U.S. are using a similar tactic to push back against the <a href="https://www.benzinga.com/news/25/01/43216758/well-go-as-far-as-im-allowed-trumps-plan-with-immigrants-starts-with-1-million-deportations">Trump administration&#8217;s immigration policies</a> and <a href="https://www.benzinga.com/news/25/01/43214683/target-ends-dei-program-following-trumps-call-to-eliminate-illegal-preferences-expert-calls-it-brand-suicide-for-retail-giant-with-diverse-customer-base">rollback of Diversity, Equity, and Inclusion programs</a>. Calling for a stop to non-essential spending, the Latino Freeze Movement has urged Latinos to &#8220;hold the line&#8221; and refrain from patronizing American companies that they perceive to be failing immigrant communities.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Campaña de los latinos contra Cocacola por apoyar las deportaciones Uuuuuuupa NO TOMEN MAS ESA BASURA. <a href="https://t.co/O6tP3DHmpK">pic.twitter.com/O6tP3DHmpK</a>
&mdash; Le petit prince (@don_juan13) <a href="https://twitter.com/don_juan13/status/1886082220227522666?ref_src=twsrc%5Etfw">February 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Videos circulating on social media show Latinos rejecting American products, with one clip depicting a family pouring Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) and Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) down the drain in protest. The movement encourages consumers to swap U.S. products for Latin American alternatives while boycotting companies like Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), and Home Depot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>).
See Also: How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.
<h2 class="wp-block-heading">The Economic and Political Impact</h2>
Latinos contribute $3.7 trillion to the U.S. economy, making their collective GDP the fifth largest in the world. The movement argues that a spending freeze could send a strong message to corporations and policymakers alike.
&#8220;Latinos and Latinas, stop spending money. Hold the line. We can all collectively make a big impact by simply holding and not spending our money,&#8221; the Latino Freeze Movement <a href="https://www.latinofreeze.com/">urges on its website</a>.
The boycott extends beyond consumer goods. Participants are encouraged to avoid big purchases, <a href="https://www.benzinga.com/news/25/02/43543459/i-love-canada-more-than-i-love-spotify-canadians-are-canceling-netflix-amazon-disney-and-spotify-en-masse-despite-the-tariff-pause">cancel subscriptions</a>, and focus spending on <a href="https://www.benzinga.com/news/24/01/36819134/mark-cuban-says-he-will-short-companies-who-think-diversity-is-negative-im-telling-you-what-i-think">businesses that support DEI</a> and immigrant rights. Companies like Costco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>), Trader Joe&#8217;s, Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), and Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) are highlighted as supportive, while major brands like Coca-Cola face scrutiny over unverified claims of cooperation with immigration enforcement agencies.
Read Next:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

AAPL

COST

NFLX

SBUX

TSLA

Full-Shopping Boycotts Sweep Europe Over High Prices—Now, One US Community Is Following Suit But For A Different Cause

Wells Fargo analyst Derek Archila maintains AnaptysBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANAB#NASDAQ">ANAB</a>) with a Overweight and raises the price target from $40 to $51.

Price Target

Analyst Ratings

ANAB

Wells Fargo Maintains Overweight on AnaptysBio, Raises Price Target to $51

Wells Fargo analyst Andrew Nowinski downgrades Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) from Overweight to Equal-Weight and lowers the price target from $152 to $140.

Downgrades

DDOG

Wells Fargo Downgrades Datadog to Equal-Weight, Lowers Price Target to $140

Mercedes from Toronto <a href="https://youtu.be/T2dA6RX35NQ?si=x0gJ_fJPz3oE0Nvm">called into The Dave Ramsey Show</a> with what seemed like a pretty standard question—until she dropped a number that left Ramsey practically speechless. She was on maternity leave and wanted to be a stay-at-home mom, but her husband wasn't on board. The catch? Her husband was making $975,000 a year.
Ramsey, never one to sugarcoat things, responded immediately: "I think you could probably freaking struggle through."
Mercedes explained that her husband was worried she'd never go back to work if she took time off. Maybe it was because his own mother had worked three jobs, she speculated. But financially, it wasn't exactly a question of whether they could afford for her to stay home—it was more about his mindset.
Don't Miss:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
</ul>
For context, in Canada, the threshold to be in the top 1% of earners is about $586,000 per year, meaning her husband was making nearly double what it takes to be in the country's top earners. Meanwhile, the average household income in Canada sits at just $67,282, according to Dundas Life. Compared to that, Mercedes and her husband were playing in an <a href="https://www.benzinga.com/news/25/02/43579097/money-well-spent-says-dave-ramsey-about-treating-himself-to-uber-luxury-bougie-travel-they-do-this-on-crazy-rich-asians">entirely different league</a>. In the U.S., the top 1% threshold is even higher, sitting around $794,129, according to The Hill.
So, with nearly a <a href="https://www.benzinga.com/personal-finance/25/02/43539942/are-you-rich-heres-what-americans-think-you-need-to-be-considered-wealthy-2">million-dollar income</a>, why was this even a discussion? Ramsey was baffled.
"It's not like you guys need the money. This is why this is so flabbergasting," he said. "Why does he go do all of that if it's not so that your family can do what they want to do?"
Mercedes admitted that she just didn't see the point in paying for a nanny when she wanted to stay home and raise their child. Ramsey agreed, pushing back against the idea that being a full-time mom was somehow less valuable than a traditional career.
Trending: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
"This idea that somehow full-time motherhood is to be shamed or looked down upon is absolute BS," he said bluntly.
He also touched on "mom guilt," pointing out that moms often feel guilty no matter what they choose—whether they work or stay home. It's a lose-lose game society has built, and Mercedes was feeling the weight of it.
Ramsey didn't just empathize—he reassured her that staying home was a valid and even highly valuable choice. "Someone was Abraham Lincoln's mother. Someone was Billy Graham's mother. Someone was Martin Luther King Jr.'s mother. This is a high calling," he said. "It has dignity. It has value. It is worth equivalent to anything you could do in the workplace."
But Ramsey also made it clear this wouldn't be a one-and-done conversation with her husband. "Don't go into this thinking this is a one-time conversation that you're gonna sway him or get him," he said. Instead, he advised her to lead with emotion—why this mattered to her personally—rather than trying to make it a purely logical argument.
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
And if that didn't work?
"Just turn off the television, take his phone away from him, set the baby in his lap, and point at the baby and say, ‘What's more important than that?'" Ramsey suggested.
And if that still didn't work? Ramsey's co-host chimed in with some advice: "Take off for about a week. Let him handle it. He will find you, honey. I'm gonna tell you right now."
Ramsey's advice might have been direct, but at its core, it boiled down to one thing: Mercedes needed to stand firm in what she wanted. If she felt strongly about staying home, it was worth pushing for—not just financially, but for the future of her family.
For families facing similar decisions, Ramsey's takeaway is clear: While finances are a big part of the equation, money alone shouldn't dictate family choices. <a href="https://www.benzinga.com/money/are-you-rich">Consulting a financial advisor</a> can help couples align their goals with their financial reality, but at the end of the day, it comes down to values. If staying home is a priority, the numbers—and the conversations—just need to follow.
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
</ul>

Personal Finance

'I Think You Could Probably Freaking Struggle Through': Dave Ramsey Shocked By New Mom Whose Husband Makes $975,000 But Won't Let Her Quit Job

Jefferies analyst Omar Nokta maintains Ardmore Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASC#NYSE">ASC</a>) with a Buy and maintains $17 price target.

Jefferies Maintains Buy on Ardmore Shipping, Maintains $17 Price Target

Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at what to <a href="https://www.benzinga.com/25/01/43306674/trumps-hhs-pick-robert-kennedy-jr-begins-senate-confirmation-hearings">expect in the report.&nbsp;</a>
What To Watch: Investors will be looking for updates on Moderna&#8217;s portfolio of mRNA-based vaccines and treatments across infectious diseases, immuno-oncology and rare diseases. COVID-19 vaccine demand and sales will be on watch.&nbsp;
Bird flu continues to spread through wild birds, poultry farms and cattle herds and updates on Moderna's development of an avian flu vaccine candidate should be watched closely.&nbsp;
Read Next: <a href="https://www.benzinga.com/25/02/43703014/robert-f-kennedy-confirmed-as-trump-secretary-of-health">Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump&#8217;s Secretary Of Health: Health Care Stocks To Watch</a>
Outspoken vaccine skeptic Robert F. Kennedy was sworn in as the<a href="https://www.benzinga.com/25/02/43703014/robert-f-kennedy-confirmed-as-trump-secretary-of-health"> new secretary</a> of Health and Human Services on Thursday and may enact policy changes that could affect regulations and Moderna's business. Executives may offer some commentary in the company's earnings call scheduled for 8 a.m. ET on Friday.&nbsp;&nbsp;
What Else: Goldman Sachs analyst Salveen Richter <a href="https://www.benzinga.com/25/01/43314068/moderna-stock-is-sliding-wednesday-heres-why">recently downgraded </a>Moderna from Buy to Neutral and lowered the price target from $99 to $51, citing lower conviction following a second product revenue guidance adjustment from the company.
According to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, analysts expect Moderna to report quarterly losses of $2.68 per share and revenue of $942.84 million. The company has beat consensus estimates on the top and bottom lines for the last four consecutive quarters.&nbsp;
MRNA Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Moderna shares ended Thursday's session up 4.54% at $31.92.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/02/43535256/palantir-adds-elon-musks-ai-chatbot-grok-to-aip">Palantir Adds Elon Musk&#8217;s AI Chatbot Grok To AIP</a></li>
</ul>
Image: Shutterstock

Health Care

Previews

Politics

Movers

General

MRNA

Moderna Q4 Earnings Preview: COVID-19 Vaccine Sales, Bird Flu Vaccine Candidates On Watch

Canaccord Genuity analyst Joseph Vafi maintains Repay Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPAY#NASDAQ">RPAY</a>) with a Buy and maintains $13 price target.

RPAY

Canaccord Genuity Maintains Buy on Repay Holdings, Maintains $13 Price Target

Canaccord Genuity analyst Joseph Vafi maintains Pagaya Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGY#NASDAQ">PGY</a>) with a Buy and maintains $25 price target.

Canaccord Genuity Maintains Buy on Pagaya Techs, Maintains $25 Price Target

Tigress Financial analyst Ivan Feinseth maintains Mastercard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>) with a Strong Buy and raises the price target from $550 to $685.

Tigress Financial Maintains Strong Buy on Mastercard, Raises Price Target to $685

Seaport Global analyst Mark Weintraub upgrades Packaging Corp of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>) from Neutral to Buy and announces $250 price target.

Upgrades

Seaport Global Upgrades Packaging Corp of America to Buy, Announces $250 Price Target

Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) with a Buy and raises the price target from $103 to $110.

GEHC

Citigroup Maintains Buy on GE HealthCare Techs, Raises Price Target to $110

Maxim Group analyst Jason McCarthy maintains INmune Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMB#NASDAQ">INMB</a>) with a Buy and raises the price target from $22 to $30.

INMB

Maxim Group Maintains Buy on INmune Bio, Raises Price Target to $30

Maxim Group analyst Anthony Vendetti maintains Nutex Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) with a Buy and raises the price target from $50 to $75.

NUTX

Maxim Group Maintains Buy on Nutex Health, Raises Price Target to $75

Lake Street analyst Ben Klieve maintains Chefs' Warehouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHEF#NASDAQ">CHEF</a>) with a Buy and raises the price target from $60 to $68.

CHEF

Lake Street Maintains Buy on Chefs' Warehouse, Raises Price Target to $68

Nukkleus has also submitted a Form S-1 registration statement registering for resale the shares of common stock issued or issuable in connection with its recent &nbsp;$10 million private placement which further reinforced its financial foundation for the Star 26 acquisition and future expansion.

NUKK

Nukkleus Formally Submits Preliminary Proxy To SEC With Respect To Proposed Acquisition Of Star 26 Capital

Lake Street initiates coverage on TriSalus Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSI#NASDAQ">TLSI</a>) with a Buy rating and announces Price Target of $10.

Initiation

TLSI

Lake Street Initiates Coverage On TriSalus Life Sciences with Buy Rating, Announces Price Target of $10

It is payable on March 26, 2025 to stockholders of record as of the close of business on March 14, 2025.

Dividends

Meta Platforms Boosts Quarterly Cash Dividend By 5% From $0.50 To $0.525 Per Share

Loop Capital analyst Garik Shmois maintains Martin Marietta Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLM#NYSE">MLM</a>) with a Buy and lowers the price target from $680 to $645.

Loop Capital Maintains Buy on Martin Marietta Materials, Lowers Price Target to $645

Loop Capital analyst Alan Gould maintains Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Buy and raises the price target from $180 to $210.

RDDT

Loop Capital Maintains Buy on Reddit, Raises Price Target to $210

Jefferies analyst Randal Konik maintains SharkNinja (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) with a Buy and raises the price target from $150 to $175.

Jefferies Maintains Buy on SharkNinja, Raises Price Target to $175

Vernon Bernardino, an analyst from H.C. Wainwright, reiterated the Buy rating on Edesa Biotech (EDSA – Research Report). The associated price targe...

Buy Rating Affirmed for Edesa Biotech Amidst Strong Government Support and Promising Drug Pipeline

Edesa Biotech ( ($EDSA) ) has issued an update. Edesa Biotech, Inc. has partnered with H.C. Wainwright & Co., LLC to periodically sell its common s...

Edesa Biotech Partners with Wainwright for Share Sales

Edesa Biotech (EDSA) has released an update. Edesa Biotech, a clinical-stage biopharmaceutical company, is set to participate in multiple internati...

Edesa Biotech to Present at Global Conferences

Edesa Biotech GAAP EPS of -$1.93 beats by $0.22

Edesa Biotech (EDSA) has released an update. Edesa Biotech reported a significant decrease in operating expenses for fiscal year 2024, with a pivot...

Edesa Biotech Enhances Financial Position and Strategy

Edesa Biotech (EDSA) announced that it has sold, in a private placement, an aggregate of 834 newly designated Series B-1 convertible preferred shar...

Edesa Biotech announces $15M private placement priced at-the-market

An announcement from Edesa Biotech ( ($EDSA) ) is now available. Edesa Biotech announced a $15 million private placement led by Velan Capital, with...

Edesa Biotech Secures $15 Million in Private Placement to Advance Clinical Programs

Edesa Biotech ( ($EDSA) ) has provided an update. Edesa Biotech has announced a $15 million private placement, led by Velan Capital, to fund its CX...

Comments

Edesa Biotech

Interés en corto

Edesa Biotech (NASDAQ:EDSA) Bolsa, Informe de interés en corto

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL